Scholarlink

<p>Early and accessible diagnosis of tuberculosis (TB) remains a global health challenge, particularly in low- and middle-income countries. Early Secreted Antigenic Target 6&#xa0;kDa (ESAT-6), released during initial infection, is a promising biomarker for TB detection. However, most current assays for TB detection depend on complex instrumentation and trained personnel, limiting their utility in resource-constrained settings. Here, we developed dual biosensing platforms based on a (Cu–S)<sub>n</sub> metal-organic framework–polyaniline (MOF–PANI) composite for ESAT-6 detection in blood plasma and urine. A paper-based microfluidic resistive immunosensor with pulsed light sintering optimization enabled quantification through resistance changes, achieving a detection range of 195 pM–50 nM with a limit of detection (LOD) of 39.2 pM in human blood plasma. In parallel, a glassy carbon electrode–based electrochemical sensor was fabricated by covalent antibody immobilization on MOF–PANI, followed by bovine serum albumin (BSA) blocking. Cyclic voltammetry revealed a detection range of 23.6 fM–1.56 nM with an ultralow LOD of 1.68 fM in artificial urine, along with excellent reproducibility and stability. Together, these results highlight the versatility of MOF–PANI composites in enabling multi-matrix ESAT-6 detection, offering complementary advantages of blood plasma-based point-of-care testing and urine-based non-invasive diagnostics. This integrated strategy shows strong potential for scalable, accessible, and accurate early TB diagnosis.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

(Cu–S)n MOF–polyaniline based dual-platform biosensing for blood plasma and urine detection of ESAT-6 toward early tuberculosis diagnosis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月20日

查看全文
  • Pei-Hsuan Chiang,
  • Zhi-Rou Liang,
  • Yi-Hua Lu,
  • Shi-Han Chen,
  • Ruei-Ting Tang,
  • Yuan-Hsiang Yu,
  • Mei-Lin Ho

摘要

Early and accessible diagnosis of tuberculosis (TB) remains a global health challenge, particularly in low- and middle-income countries. Early Secreted Antigenic Target 6 kDa (ESAT-6), released during initial infection, is a promising biomarker for TB detection. However, most current assays for TB detection depend on complex instrumentation and trained personnel, limiting their utility in resource-constrained settings. Here, we developed dual biosensing platforms based on a (Cu–S)n metal-organic framework–polyaniline (MOF–PANI) composite for ESAT-6 detection in blood plasma and urine. A paper-based microfluidic resistive immunosensor with pulsed light sintering optimization enabled quantification through resistance changes, achieving a detection range of 195 pM–50 nM with a limit of detection (LOD) of 39.2 pM in human blood plasma. In parallel, a glassy carbon electrode–based electrochemical sensor was fabricated by covalent antibody immobilization on MOF–PANI, followed by bovine serum albumin (BSA) blocking. Cyclic voltammetry revealed a detection range of 23.6 fM–1.56 nM with an ultralow LOD of 1.68 fM in artificial urine, along with excellent reproducibility and stability. Together, these results highlight the versatility of MOF–PANI composites in enabling multi-matrix ESAT-6 detection, offering complementary advantages of blood plasma-based point-of-care testing and urine-based non-invasive diagnostics. This integrated strategy shows strong potential for scalable, accessible, and accurate early TB diagnosis.

Graphical Abstract